Exploratory analysis of diabetic retinopathy progression through 3 years in a randomized clinical trial that compares intravitreal triamcinolone acetonide with focal/grid photocoagulation

Archives of Ophthalmology

Volumn 127, Issue 12, 2009, Pages 1566-1571

  Bressler, Neil M ^a   Edwards, Allison R ^b   Beck, Roy W ^b   Flaxel, Christina J ^c   Glassman, Adam R ^b   Ip, Michael S ^d   Kollman, Craig ^b   Kuppermann, Baruch D ^e   Stone, Thomas W ^f  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JAEB CENTER FOR HEALTH RESEARCH   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f Retina Associates of Kentucky   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRIAMCINOLONE ACETONIDE; GLUCOCORTICOID;

ADULT; ARTICLE; CATARACT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFECT; EYE PHOTOGRAPHY; FEMALE; GLAUCOMA; HUMAN; INTERMETHOD COMPARISON; LASER COAGULATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; TREATMENT OUTCOME; VITREOUS HEMORRHAGE; COMPARATIVE STUDY; FOLLOW UP; INJECTION; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROBABILITY; RETINA MACULA EDEMA; VISUAL ACUITY; VITREOUS BODY;

DIABETIC RETINOPATHY; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; INJECTIONS; LASER COAGULATION; MACULAR EDEMA; MALE; MIDDLE AGED; PROBABILITY; TRIAMCINOLONE ACETONIDE; VISUAL ACUITY; VITREOUS BODY;

EID: 73349135368     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2009.308     Document Type: Article

References (24)

1. Diabetic Retinopathy Study Research Group. Preliminary report on effects of photocoagulation therapy. Am J Ophthalmol. 1976;81(4):383-396.
2. Aiello LP. Angiogenic pathways in diabetic retinopathy. N Engl J Med. 2005;353 (8):839-841.
3. Diabetes Control and Complications Trial Research Group. The effect of intensive diabetic treatment on the progression of diabetic retinopathy in insulindependent diabetes mellitus: the Diabetes Control and Complications Trial. Arch Ophthalmol. 1995;113(1):36-51.
4. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998; 352(9131):837-853.
5. Ferris FL III, Patz A. Macular edema: a complication of diabetic retinopathy. Surv Ophthalmol. 1984;28(suppl):452-461.
6. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study report No. 4. Int Ophthalmol Clin. 1987;27(4):265-272.
7. Chew EY, Ferris FL III, Csaky KG, et al. The long-term effects of laser photocoagulation treatment in patients with diabetic retinopathy: the early treatment diabetic retinopathy follow-up study. Ophthalmology. 2003;110(9):1683-1689.
8. Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy: ETDRS report number 9. Ophthalmology. 1991; 98(5)(suppl):766-785.
9. Díaz-Flores L, Gutiérrez R, Varela H. Angiogenesis: an update. Histol Histopathol. 1994;9(4):807-843.
10. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971; 285(21):1182-1186.
11. Challa JK, Gillies MC, Penfold PL, Gyory JF, Hunyor AB, Billson FA. Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up. Aust N Z J Ophthalmol. 1998;26(4):277-281.
12. Penfold PL, Gyory JF, Hunyor AB, Billson FA. Exudative macular degeneration and intravitreal triamcinolone: a pilot study. Aust N Z J Ophthalmol. 1995;23 (4):293-298.
13. Antoszyk AN, Gottlieb JL, Machemer R, Hatchell DL. The effects of intravitreal triamcinolone acetonide on experimental pre-retinal neovascularization. Graefes Arch Clin Exp Ophthalmol. 1993;231(1):34-40.
14. Danis RP, Bingaman DP, Yang Y, Ladd B. Inhibition of preretinal and optic nerve head neovascularization in pigs by intravitreal triamcinolone acetonide. Ophthalmology. 1996;103(12):2099-2104.
15. Ip MS, Bressler SB, Antoszyk AN, et al; Diabetic Retinopathy Clinical Research Network. A randomized trial comparing intravitreal triamcinolone and focal/grid photocoagulation for diabetic macular edema: baseline features. Retina. 2008;28 (7):919-930.
16. Diabetic Retinopathy Clinical Research Network. A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema. Ophthalmology. 2008;115(9):1447-1449, 1449, e1-e10. http://download.journals.elsevierhealth.com/pdfs/journals /0161-6420/PIIS0161642008006064.pdf.
17. Diabetic Retinopathy Clinical Research Network Web site. Complete study protocol. http://public.drcr.net/DRCRnetstudies/studies/ProtocolB-steroid/ ProtBInfo .html. Accessed September 8, 2009.
18. Beck RW, Moke PS, Turpin AH, et al. A computerized method of visual acuity testing: adaptation of the early treatment of diabetic retinopathy study testing protocol. Am J Ophthalmol. 2003;135(2):194-205.
19. Lee EW, Wei LJ, Amato DA. Cox-Type Regression Analysis for Large Numbers of Small Groups of Correlated Failure Time Observations. Dordrecht, Germany: Kluwer Academic Publishers; 1992:237-247.
20. Gardner TW, Antonetti DA. Novel potential mechanisms for diabetic macular edema: leveraging new investigational approaches. Curr Diab Rep. 2008;8(4):263-269.
21. King GL. The role of inflammatory cytokines in diabetes and its complications. J Periodontol. 2008;79(8)(suppl):1527-1534.
22. Adamis AP, Berman AJ. Immunological mechanisms in the pathogenesis of diabetic retinopathy. Semin Immunopathol. 2008;30(2):65-84.
23. Kern TS. Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp Diabetes Res. 2007;2007:95103.
24. Fluocinolone acetonide intravitreal implant to treat diabetic macular edema: 3-year results of a multi-center clinical trial. Investigative Ophthalmology and Visual Science Web site. http://abstracts.iovs.org/cgi/ content/abstract/47/5/5442?maxtoshow =&HITS=10&hits=10&RESULTFORMAT= &author1= PEARSON&andorexactfulltext =and&searchid= 1&FIRSTINDEX= 10&resourcetype= HWCIT. Accessed September 15, 2009.